Funding Details
- Awarder
- Inbox
- Date Award
- April 26, 2017
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
-
$45,500,000
Company Info
- Company Description
- Arsanis is a biopharmaceutical company developing infectious disease treatments based on bacterial protein and carbohydrate antigens.
- Market
- Infectious Diseases
- Location
-
Waltham,
MA,
USA
- Coinvestors
- Alexandria Real Estate Equities, Bill & Melinda Gates Foundation, EMBL Ventures, NeoMed Management, OrbiMed Advisors, Polaris Partners, Stephen Kellen Foundation, SV Health Investors
Links